Valuation, from the filing
| Public float | $4.25B | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|---|---|
| Float per share | $13.48 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / revenue | 13.3× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
How this compares in its industry
Percentile among the Finance Services filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| CapEx / revenue | 228.5% | 92th | |
| Revenue YoY growth | -37.5% | 11th | |
| Gross margin | 11.9% | 23th | |
| FCF margin | -141.3% | 27th | |
| SBC / revenue | 30.8% | 66th | |
| Operating margin | -77.0% | 62th | |
| Current ratio | 1.15x | 41th | |
| Net margin | -90.5% | 55th |
Core Scientific, Inc./tx (CORZ) reported revenue of $164.20M and net income of -$1.16B for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Core Scientific, Inc./tx’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Finance Services.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $164.20M | $115.24M | $79.76M | $81.10M | $78.63M | $79.52M | $94.92M | $95.35M | $141.10M | $179.29M |
| Cost of revenue | $94.16M | $85.14M | $59.01M | $77.20M | $73.60M | $71.31M | $90.16M | $95.51M | $102.28M | $101.64M |
| Gross profit | $70.04M | $30.11M | $20.76M | $3.90M | $5.02M | $8.21M | $4.76M | -$156.00K | $38.82M | $77.65M |
| Operating income | -$78.47M | -$310.42M | -$117.48M | -$54.79M | -$26.28M | -$47.04M | -$65.39M | -$41.22M | -$90.68M | $55.23M |
| Net income | -$1.16B | -$347.19M | $215.96M | -$144.03M | -$936.80M | $576.25M | -$291.15M | -$455.26M | -$902.16M | $210.69M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $5.02M | $2.84M | $2.17M | $1.80M |
| Weighted-average diluted shares | shares 325.33M | shares 322.91M | Unavailable | shares 318.56M | Unavailable | shares 363.31M | Unavailable | shares 292.49M | shares 178.50M | shares 282.53M |
| Pretax income | -$1.15B | -$346.59M | $216.05M | -$143.90M | -$936.64M | $576.46M | -$290.77M | -$455.12M | -$902.01M | $210.90M |
| Income tax expense | $1.91M | $600.00K | $95.00K | $125.00K | $158.00K | $205.00K | $375.00K | $134.00K | $144.00K | $206.00K |
| Diluted EPS | $-3.32 | $-1.06 | Unavailable | $-0.45 | $-0.04 | $1.24 | $-0.69 | $-1.17 | $-5.05 | $0.78 |
| Selling, general & administrative | $49.39M | $44.85M | -$11.63M | $69.35M | $45.28M | $32.29M | $25.04M | $40.35M | $31.38M | $16.92M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $35.71M | $34.36M | $26.24M | $14.14M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $2.87M | $3.15M | $2.97M | $982.00K |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.77B | $1.01B | $311.38M | $453.44M | $581.34M | $697.94M | $836.20M | $253.02M | $96.12M | $98.12M |
| Total assets | $5.26B | $3.07B | $2.35B | $2.17B | $1.85B | $1.50B | $1.48B | $824.59M | $664.20M | $813.97M |
| Current assets | $2.44B | $1.45B | $895.54M | $1.06B | $1.00B | $833.18M | $903.96M | $277.86M | $117.86M | $143.32M |
| Total liabilities | $7.68B | $4.38B | $3.31B | $3.42B | $3.04B | $1.81B | $2.42B | $1.65B | $1.85B | $1.13B |
| Current liabilities | $2.74B | $2.66B | $781.40M | $669.86M | $562.72M | $195.51M | $134.56M | $76.51M | $74.82M | $138.14M |
| Total equity incl. NCI | -$2.42B | -$1.31B | -$962.74M | -$1.25B | -$1.19B | -$308.82M | -$943.05M | -$826.66M | -$1.18B | -$318.51M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $1.02M | $1.02M | $6.24M | $4.68M | $1.11M |
| Goodwill | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | $4.30B | $1.06B | $1.06B | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $112.37M | $218.86M | $126.11M | $212.18M | $215.06M | $6.33M | $19.26M | $6.50M | $8.49M | $16.16M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$18.93M | $249.88M | $157.51M | $131.78M | $34.00M | -$45.04M | $13.80M | $5.71M | $1.20M | $22.17M |
| Capital expenditures | $565.02M | $389.23M | $279.25M | $244.49M | $121.28M | $83.98M | $28.76M | $31.17M | $3.14M | $31.89M |
| Investing cash flow | -$796.24M | -$386.65M | -$277.77M | -$254.36M | -$119.61M | -$89.02M | -$28.80M | -$31.24M | -$3.18M | -$31.97M |
| Financing cash flow | $2.22B | $971.38M | -$21.81M | -$5.32M | -$31.77M | -$4.20M | $598.17M | $182.22M | -$15.19M | $54.36M |
| Net change in cash | $1.41B | $834.61M | -$142.06M | -$127.90M | -$117.38M | -$138.26M | $583.18M | $156.70M | -$17.17M | $44.57M |
| Stock-based compensation | $18.24M | $17.76M | $27.94M | $29.95M | $24.17M | $16.18M | $23.97M | $20.52M | $8.49M | -$1.06M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $15.50M | $16.65M | $14.10M | $16.33M | $18.76M | $19.73M | $26.04M | $28.69M | $29.48M | $29.00M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$583.95M | -$139.35M | -$121.74M | -$112.71M | -$87.28M | -$129.02M | -$14.95M | -$25.46M | -$1.93M | -$9.72M |
| Gross margin | 42.7% | 26.1% | 26.0% | 4.8% | 6.4% | 10.3% | 5.0% | -0.2% | 27.5% | 43.3% |
| Operating margin | -47.8% | -269.4% | -147.3% | -67.6% | -33.4% | -59.1% | Unavailable | -43.2% | -64.3% | 30.8% |
| FCF margin | -355.6% | -120.9% | -152.6% | -139.0% | -111.0% | -162.2% | -15.8% | -26.7% | -1.4% | -5.4% |
| SBC / revenue | 11.1% | 15.4% | 35.0% | 36.9% | 30.7% | 20.4% | 25.2% | 21.5% | 6.0% | -0.6% |
| Current ratio | 0.89x | 0.55x | 1.15x | 1.58x | 1.79x | 4.26x | 6.72x | 3.63x | 1.58x | 1.04x |
| Revenue YoY growth | 108.8% | 44.9% | -16.0% | -14.9% | -44.3% | -55.6% | -33.1% | -15.5% | 11.2% | 48.6% |
| Net margin | -703.6% | -301.3% | 270.8% | -177.6% | -1191.4% | 724.6% | Unavailable | -477.4% | -639.4% | 117.5% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 344.1% | 337.7% | 350.1% | 301.5% | 154.2% | 105.6% | 30.3% | 32.7% | 2.2% | 17.8% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | 0.0% | Unavailable | Unavailable | 0.0% | Unavailable | Unavailable | Unavailable | 0.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CORZ in the interactive workspace to inspect any figure back to its filing.
Source filings
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.